Trials / Unknown
UnknownNCT02327819
The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Supplementation of BCAA found to reduce the risk of developing liver cancer, but the affect of BCAA on existing liver cancer is unknown. The participants (post curative intent surgery) will be supplemented with either BCAA/non-BCAA-enriched protein supplement. The intervantion will go on for 2 years or until a new liver tumor is found.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Branched-chain amoni acids (BCAA) | |
| DIETARY_SUPPLEMENT | non-BCAA protein supplement |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- First posted
- 2014-12-30
- Last updated
- 2014-12-30
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02327819. Inclusion in this directory is not an endorsement.